As of Feb 05
| -1.72 / -5.17%|
The 5 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 45.00, with a high estimate of 54.00 and a low estimate of 39.00. The median estimate represents a +42.68% increase from the last price of 31.54.
The current consensus among 6 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.